Drugs Health Pharma

Novo Nordisk unveils new drug to fight obesity, says 13% effective

HQ Team March 11, 2024: Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company.

Read More
Drugs Health Pharma

Pfizer’s pediatric leukaemia drug gets regulator FDA’s green light

HQ Team March 7, 2024: The FDA has approved Pfizer’s Besponsa drug for pediatric patients aged one year and above to treat acute.

Read More
Drugs Health Pharma

German male injects Covid-19 vaccines 217 times, immunity didn’t weaken

HQ Team March 7, 2024: An 82-year-old German male, who took Covid-19 vaccine 217 times, did not have his immune system weakened but.

Read More
Climate Health Pharma

Arctic may be ice-free for a month by mid-century: UC Boulder researchers

HQ Team March 7, 2024: Greenhouse gas emissions will rob the Arctic ice as early as the 2030s in summer, resulting in a significant impact.

Read More
Climate Medical Pharma

New chip to aid weather scientists, astronomers, cellphone firms

HQ Team March 7, 2024: A chip, developed by the US-based National Institute of Standards and Technology, to convert light into microwaves, can.

Read More
Drugs Health Pharma

Novo Nordisk says Ozempic reduces kidney disease progression 

HQ Team March 6, 2024: Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney deaths in 24%.

Read More
Drugs Health Pharma

Opinion: Ignore fitspo, embrace body neutrality to counter dysmorphia

By Aparna S March 5, 2024: “My body is not yours to critique and discuss. My body is not yours for consumption. My.

Read More
Drugs Health Pharma

Akero Therapeutics says mid-stage trials on drug for fatty liver disease positive

HQ Team March 4, 2024: US-based Akero Therapeutics, Inc., announced its mid-trial of a drug to treat fatty liver disease met its primary.

Read More
Drugs Health Pharma

Bayer acquires marketing rights for heart drug in Europe for $310 million

HQ Team March 4, 2024: Bayer AG, a German multinational pharmaceutical and biotechnology company, has bought the marketing rights in Europe for a.

Read More
Climate Health Pharma

Divergent scientific views emerge on “shocking” record low ice in Antarctica

HQ Team March 3, 2024: A third consecutive year of record low sea ice levels in the Antarctic sea is “shocking” geologists and.

Read More